Literature DB >> 11786109

Relationship between volume status and blood pressure during chronic hemodialysis.

John K Leypoldt1, Alfred K Cheung, James A Delmez, Jennifer J Gassman, Nathan W Levin, Julia A Breyer Lewis, James L Lewis, Michael V Rocco.   

Abstract

BACKGROUND: The relationship between volume status and blood pressure (BP) in chronic hemodialysis (HD) patients remains incompletely understood. Specifically, the effect of interdialytic fluid accumulation (or intradialytic fluid removal) on BP is controversial.
METHODS: We determined the association of the intradialytic decrease in body weight (as an indicator of interdialytic fluid gain) and the intradialytic decrease in plasma volume (as an indicator of postdialysis volume status) with predialysis and postdialysis BP in a cross-sectional analysis of a subset of patients (N=468) from the Hemodialysis (HEMO) Study. Fifty-five percent of patients were female, 62% were black, 43% were diabetic and 72% were prescribed antihypertensive medications. Dry weight was defined as the postdialysis body weight below which the patient developed symptomatic hypotension or muscle cramps in the absence of edema. The intradialytic decrease in plasma volume was calculated from predialysis and postdialysis total plasma protein concentrations and was expressed as a percentage of the plasma volume at the beginning of HD.
RESULTS: Predialysis systolic and diastolic BP values were 153.1 +/- 24.7 (mean +/- SD) and 81.7 +/- 14.8 mm Hg, respectively; postdialysis systolic and diastolic BP values were 136.6 +/- 22.7 and 73.9 +/- 13.6 mm Hg, respectively. As a result of HD, body weight was reduced by 3.1 +/- 1.3 kg and plasma volume was contracted by 10.1 +/- 9.5%. Multiple linear regression analyses showed that each kg reduction in body weight during HD was associated with a 2.95 mm Hg (P=0.004) and a 1.65 mm Hg (P=NS) higher predialysis and postdialysis systolic BP, respectively. In contrast, each 5% greater contraction of plasma volume during HD was associated with a 1.50 mm Hg (P=0.026) and a 2.56 mm Hg (P < 0.001) lower predialysis and postdialysis systolic BP, respectively. The effects of intradialytic decreases in body weight and plasma volume were greater on systolic BP than on diastolic BP.
CONCLUSIONS: HD treatment generally reduces BP, and these reductions in BP are associated with intradialytic decreases in both body weight and plasma volume. The absolute predialysis and postdialysis BP levels are influenced differently by acute intradialytic decreases in body weight and acute intradialytic decreases in plasma volume; these parameters provide different information regarding volume status and may be dissociated from each other. Therefore, evaluation of volume status in chronic HD patients requires, at minimum, assessments of both interdialytic fluid accumulation (or the intradialytic decrease in body weight) and postdialysis volume overload.

Entities:  

Mesh:

Year:  2002        PMID: 11786109     DOI: 10.1046/j.1523-1755.2002.00099.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  33 in total

1.  Role of arachidonoylethanolamine in blood pressure regulation in volume-resistant patients on peritoneal dialysis.

Authors:  Qiong Bai; Jing Zhang; Ai-Hua Zhang; Li-Tao Cheng; Jing-Li Duan; Lian He; Ya-Jun Luo; Min-Hua Fan; Yue Wang; Tao Wang
Journal:  Int Urol Nephrol       Date:  2012-03-24       Impact factor: 2.370

Review 2.  Special situations: Intradialytic hypertension/chronic hypertension and intradialytic hypotension.

Authors:  Peter Noel Van Buren; Jula K Inrig
Journal:  Semin Dial       Date:  2017-06-30       Impact factor: 3.455

3.  The relationship between chronic volume overload and elevated blood pressure in hemodialysis patients: use of bioimpedance provides a different perspective from echocardiography and biomarker methodologies.

Authors:  Luminita Voroneanu; Claudiu Cusai; Simona Hogas; Serban Ardeleanu; Mihai Onofriescu; Ionut Nistor; Octavian Prisada; Radu Sascau; David Goldsmith; Adrian Covic
Journal:  Int Urol Nephrol       Date:  2010-06-04       Impact factor: 2.370

4.  Quantification of autonomic nervous activity by heart rate variability and approximate entropy in high ultrafiltration rate during hemodialysis.

Authors:  Yoshihiro Tsuji; Naoki Suzuki; Yasumasa Hitomi; Toshiko Yoshida; Yuko Mizuno-Matsumoto
Journal:  Clin Exp Nephrol       Date:  2016-08-01       Impact factor: 2.801

Review 5.  Evaluation and Treatment of Hypertension in End-Stage Renal Disease Patients on Hemodialysis.

Authors:  Peter Noel Van Buren
Journal:  Curr Cardiol Rep       Date:  2016-12       Impact factor: 2.931

6.  Assessing Extracellular Volume in Hemodialysis Patients Using Intradialytic Blood Pressure Slopes.

Authors:  Hao Liu; Rong Lu; Shani Shastri; Mark Sonderman; Peter Noel Van Buren
Journal:  Nephron       Date:  2018-02-13       Impact factor: 2.847

7.  Chronobiology of arterial hypertension in hemodialysis patients: implications for home blood pressure monitoring.

Authors:  Rajiv Agarwal; Robert P Light
Journal:  Am J Kidney Dis       Date:  2009-06-10       Impact factor: 8.860

8.  Outbreak of adverse reactions associated with contaminated heparin.

Authors:  David B Blossom; Alexander J Kallen; Priti R Patel; Alexis Elward; Luke Robinson; Ganpan Gao; Robert Langer; Kiran M Perkins; Jennifer L Jaeger; Katie M Kurkjian; Marilyn Jones; Sarah F Schillie; Nadine Shehab; Daniel Ketterer; Ganesh Venkataraman; Takashi Kei Kishimoto; Zachary Shriver; Ann W McMahon; K Frank Austen; Steven Kozlowski; Arjun Srinivasan; George Turabelidze; Carolyn V Gould; Matthew J Arduino; Ram Sasisekharan
Journal:  N Engl J Med       Date:  2008-12-03       Impact factor: 91.245

Review 9.  Long-term outcome of chronic dialysis in children.

Authors:  Rukshana Shroff; Sarah Ledermann
Journal:  Pediatr Nephrol       Date:  2008-01-23       Impact factor: 3.714

10.  Guided optimization of fluid status in haemodialysis patients.

Authors:  Petr Machek; Tomas Jirka; Ulrich Moissl; Paul Chamney; Peter Wabel
Journal:  Nephrol Dial Transplant       Date:  2009-09-30       Impact factor: 5.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.